Participants

KL Kimberly LeBlanc
EK Emily G. Kelley
AN Anna Nagy
JB Jorick Bater
TB Tala Berro
MM Molly A. McGuinness
CS Courtney Studwell
MM Matthew Might
ask Ask a question
Favorite

UDN participants and parents/guardians of participants were invited to take part in this study. To be eligible, participants were required to have undergone evaluation through one of the UDN clinical sites and determined by the site to potentially benefit from the sharing of information publicly. The site’s decision was based on genotypic and phenotypic findings that could benefit from matching with similar individuals. All participants and parents/guardians who expressed interest and met the inclusion criteria were contacted regarding participation from April 14, 2016 to April 13, 2020 by research assistants at the UDN Coordinating Center, which manages network-wide activities. The study protocol was approved by the NIH Institutional Review Board (IRB) (protocol 15-HG-0130).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A